Genetic Variants of Voltage-Gated Ca+2 Channel Genes, cacna1c and cacnb2, Conferring the Risk of Schizophrenia in Patients from Pakistan
Abstract
Schizophrenia (SCZ) is a chronic mental disorder with a lifetime risk of approximately 1%. It is characterized by a profound disruption in cognition, behavior, and sensation with heritability estimated at up to 80%. It is a disorder with a complex etiology that involves multiple and heterogeneous genetic factors. The polygenic model of genetic susceptibility of psychiatric diseases explains that genetic variants of multiple genes determine the overall risk of disease because of their multiplicative effect. Two subunits of voltage-gated calcium channels, cacna1c and cacnb2 genes, play important roles in balancing calcium in brain cells, and their single-nucleotide polymorphisms (SNPs) have been associated differently with schizophrenia risk in different ethnicities. Two SNPs (rs1006737 & 4765913) of the cacna1c gene and a SNP (rs12257556) of the cacnb2 gene have been associated with schizophrenia. In this study, confirmed diagnosed schizophrenia patients and age-matched healthy control subjects were analyzed for the association of SNPs (rs1006737, 4765913 & rs12257556) with schizophrenia risk in Pakistani patients. Both SNPs of the cacna1c gene (rs1006737 and rs4765913) showed significant association with schizophrenia risk in this population. Moreover, two haplotypes (AT and GA) out of four for SNPs (rs1006737, rs4765913) of cacna1c further verified their significant association with the risk of schizophrenia. For cacnb2 , no significant association with the risk of schizophrenia in the SNP (rs12257556) was observed. The results of this study offer compelling evidence of a strong link between cacna1c polymorphisms (individual variant & haplotypes) and schizophrenia risk in the Pakistani population.
Keywords: single-nucleotide polymorphisms, rs1006737, rs4765913, rs12257556.
Full Text:
PDFReferences
LIEBERMAN J A, STROUP T S, MCEVOY J P, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 2005, 353(12): 1209-1223. https://doi.org/10.1056/NEJMoa051688
LOZANO R, NAGHAVI M, FOREMAN K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 2012, 380(9859): 2095-2128. https://doi.org/10.1016/S0140-6736(12)61728-0
MELTZER H Y, and BALDESSARINI R J. Reducing the risk for suicide in schizophrenia and affective disorders. The Journal of Clinical Psychiatry, 2003, 64(9): 1122-1129. https://doi.org/10.4088/JCP.v64n0920
ZULLINO D F, WABER L, and KHAZAAL Y. Cannabis and the course of schizophrenia. American Journal of Psychiatry, 2008, 165(10): 1357-1358. https://doi.org/10.1176/appi.ajp.2008.08040618
GAUTHIER J, CHAMPAGNE N, LAFRENIÈRE R G, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proceedings of the National Academy of Sciences, 2010, 107(17): 7863-7868. https://doi.org/10.1073/pnas.0906232107
HARRISON P J, and WEINBERGER D R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 2005, 10(1): 40-68. https://doi.org/10.1038/sj.mp.4001558
MUESER K T, and MCGURK S R. Schizophrenia. Lancet, 2004, 363(9426): 2063-72. https://doi.org/10.1016/S0140-6736(04)16458-1
WALSH T, MCCLELLAN J M, MCCARTHY S E, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 2008, 320(5875): 539-543. https://doi.org/10.1126/science.1155174
CARDNO A G, and GOTTESMAN I I. Twin studies of schizophrenia: from bow‐and‐arrow concordances to star wars Mx and functional genomics. American Journal of Medical Genetics, 2000, 97(1): 12-17. https://doi.org/10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U
GREIG T C, ZITO W, WEXLER B E, et al. Improved cognitive function in schizophrenia after one year of cognitive training and vocational services. Schizophrenia Research, 2007, 96(1-3): 156-161. https://doi.org/10.1016/j.schres.2007.07.003
SMOLLER J W, and FINN C T. Family, twin, and adoption studies of bipolar disorder. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2003, 123(1): 48-58. https://doi.org/10.1002/ajmg.c.20013
MOOSMANG S, HAIDER N, KLUGBAUER N, et al. Role of hippocampal Cav1. 2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. Journal of Neuroscience, 2005, 25(43): 9883-9892. https://doi.org/10.1523/JNEUROSCI.1531-05.2005
SHIBASAKI M, KUROKAWA K, & OHKUMA S. Upregulation of L‐type Cav1 channels in the development of psychological dependence. Synapse, 2010, 64(6): 440-444. https://doi.org/10.1002/syn.20745
RIPKE S, O'DUSHLAINE C, CHAMBERT K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics, 2013, 45(10): 1150-1159. https://doi.org/10.1038/ng.2742
SCHMITT A, MALCHOW B, HASAN A, and FALKAI P. The impact of environmental factors in severe psychiatric disorders. Frontiers in Neuroscience, 2014, 8: 19. https://doi.org/10.3389/fnins.2014.00019
TESLI M, SKATUN K C, OUSDAL O T, et al. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PloS One, 2013, 8(2): e56970. https://doi.org/10.1371/journal.pone.0056970
JOGIA J, RUBERTO G, LELLI-CHIESA G, et al. The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Molecular Psychiatry, 2011, 16(11): 1070-1071. https://doi.org/10.1038/mp.2011.49
LEE M T M, CHEN C H, LEE C S, et al. Genome-wide association study of bipolar I disorder in the Han Chinese population. Molecular Psychiatry, 2011, 16(5): 548-556. https://doi.org/10.1038/mp.2010.43
BURAEI Z, and YANG J. Structure and function of the β subunit of voltage-gated Ca2+ channels. Biochimica Et Biophysica Acta (BBA)-Biomembranes, 2013, 1828(7): 1530-1540. https://doi.org/10.1016/j.bbamem.2012.08.028
KOBAYASHI, T, YAMADA, Y, FUKAO, M, TSUTSUURA, M, and TOHSE, N. Regulation of Cav1. 2 current: interaction with intracellular molecules. Journal of Pharmacological Sciences, 2007, 103(4): 347-353. https://doi.org/10.1254/jphs.CR0070012
GOMEZ-OSPINA N, TSURUTA F, BARRETO-CHANG O, HU L, and DOLMETSCH R. The C terminus of the L-type voltage-gated calcium channel CaV1. 2 encodes a transcription factor. Cell, 2006, 127(3): 591-606. https://doi.org/10.1016/j.cell.2006.10.017
PEREZ-REYES E, WEI X Y, CASTELLANO A, and BIRNBAUMER L. Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes. Journal of Biological Chemistry, 1990, 265(33): 20430-20436. https://doi.org/10.1016/S0021-9258(17)30522-7
JURAEVA D, HAENISCH B, ZAPATKA M, et al. Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. PLoS Genetics, 2014, 10(6): e1004345. https://doi.org/10.1371/journal.pgen.1004345
HIROTSU N, MURAKAMI N, KASHIWAGI T, UJIIE, K, and ISHIMARU K. Protocol: a simple gel-free method for SNP genotyping using allele-specific primers in rice and other plant species. Plant Methods, 2010, 6(1): 1-10. https://doi.org/10.1016/j.pediatrneurol.2022.10.013
LI Z, ZHANG Z, HE Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis. bio-x. cn). Cell Research, 2009, 19(4): 519-523. https://doi.org/10.1007/s00127-014-0823-2
LEVY R J, TIMOTHY K W, UNDERWOOD J F, et al. A cross-sectional study of the neuropsychiatric phenotype of CACNA1C-related disorder. Pediatric Neurology, 2023, 138: 101-106. https://doi.org/10.1016/j.pediatrneurol.2022.10.013
IYEGBE C, CAMPBELL D, BUTLER A, et al. The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. Social Psychiatry and Psychiatric Epidemiology, 2014, 49: 169-182. https://doi.org/10.1007/s00127-014-0823-2
PSYCHIATRIC GWAS CONSORTIUM BIPOLAR DISORDER WORKING GROUP. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics, 2011, 43(10): 977-983.
SULLIVAN P F. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nature Medicine, 2012, 18(2): 210-211. https://doi.org/10.1038/nm.2670
MOON A L, HAAN N, WILKINSON L S, et al. CACNA1C: association with psychiatric disorders, behavior, and neurogenesis. Schizophrenia Bulletin, 2018, 44(5): 958-965. https://doi.org/10.1093/schbul/sby096
PANTELIS C, PAPADIMITRIOU G. N, PAPIOL S, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature, 2014, 511(7510): 421-427. https://doi.org/10.1038/nature13595
ANDRADE A, BRENNECKE A, MALLAT S, et al. Genetic associations between voltage-gated calcium channels and psychiatric disorders. International Journal of Molecular Sciences, 2019, 20(14): 3537. https://doi.org/10.3390/ijms20143537
CROSS-DISORDER GROUP OF THE PSYCHIATRIC GENOMICS CONSORTIUM. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. The Lancet, 2013, 381(9875): 1371-1379. https://doi.org/10.1016/S0140-6736(12)62129-1
CHEN M, JIANG Q, and ZHANG L. CACNA1C gene rs1006737 polymorphism affects cognitive performance in Chinese Han schizophrenia. Neuropsychiatric Disease and Treatment, 2022, 1697-1704. https://doi.org/10.2147/NDT.S373492
IVORRA J L, RIVERO O, COSTAS J, INIESTA, R, et al. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case–control sample from Spain. Schizophrenia Research, 2014, 159(1): 107-113. https://doi.org/10.1016/j.schres.2014.07.004
WANG Z, CHEN W, CAO Y, et al. An independent, replicable, functional and significant risk variant block at intron 3 of CACNA1C for schizophrenia. The Australian and New Zealand Journal of Psychiatry, 2022, 56: 385-397. https://doi.org/10.1177/00048674211009595
LIU Y P, WU X, XIA X, et al. The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis. BMC Medical Genetics, 2020, 21: 159. https://doi.org/10.1186/s12881-020-01084-0
NYEGAARD M, DEMONTIS D, FOLDAGER L, et al. CACNA1C (rs1006737) is associated with schizophrenia. Molecular Psychiatry, 2020, 15: 119-121. https://doi.org/10.1038/mp.2009.69
HE K, AN Z, WANG Q, et al. CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. The British Journal of Psychiatry: The Journal of Mental Science, 2014, 204: 36-39. https://doi.org/10.1192/bjp.bp.113.126979
BASTOS C R, TOVO-RODRIGUES L, ARDAIS A P, et al. The role of CACNA1C gene and childhood trauma interaction on bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2020, 101: 109915. https://doi.org/10.1016/j.pnpbp.2020.109915
KANTOJÄRVI K, LIUHANEN J, SAARENPÄÄ-HEIKKILÄ O, et al. Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants. PloS One, 2017, 12(8): e0180652. https://doi.org/10.1371/journal.pone.0180652
LICHTENSTEIN P, YIP B H, BJORK C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. The Lancet, 2009, 373: 234-239. https://doi.org/10.1016/S0140-6736(09)60072-6
LU A T, DAI X, MARTINEZ-AGOSTO J A, and CANTOR R M. Support for calcium channel gene defects in autism spectrum disorders. Molecular Autism, 2012, 3: 18. https://doi.org/10.1186/2040-2392-3-18
SKAFIDAS E, TESTA R, ZANTOMIO D, et al. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Molecular Psychiatry, 2014, 19: 504-510. https://doi.org/10.1038/mp.2012.126
VUORI N, SANDHOLM N, KUMAR A, et al. CACNB2 is a novel susceptibility gene for diabetic retinopathy in type 1 diabetes. Diabetes, 2019, 68(11): 2165-2174. https://doi.org/10.2337/db19-0130
CALVO P M, HERNÁNDEZ R G, PASTOR A M, and DE LA CRUZ R R. VEGF and Neuronal Survival. The Neuroscientist, 2022, 10738584221120803. https://doi.org/10.1177/10738584221120803
PILLAI A, HOWELL K R, AHMED A O, et al. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 2016, 21(5): 686-692. https://doi.org/10.1038/mp.2015.96
BEASLEY C L, PENNINGTON K, BEHAN A, et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics, 2006, 6; 3414-3425. https://doi.org/10.1002/pmic.200500069
BERTOLINO A, and BLASI G. The genetics of schizophrenia. Neuroscience, 2009, 164: 288-299. https://doi.org/10.1016/j.neuroscience.2009.04.038
Refbacks
- There are currently no refbacks.
